Profound Medical Corp's stock is feeling the heat, dipping 1.82% in the last trading session.
In a challenging trading session, Profound Medical Corp (PRN.TO) saw its shares decline by 1.82%, closing at CA$9.17. This downturn raises questions about investor confidence and market sentiment surrounding the company’s recent activities and future outlook.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$365.19M
52W high
$12.40
52W low
$5.23
1W change
-2.87%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 146.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+146.4% Upside
Current Price
C$10.16
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
42.5%
Annualized
90-Day Vol
82.2%
Annualized
Trend (90d)
+45.4%
Annualized drift
90d Mean
C$11.95
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.72 | C$9.26 – C$12.42 |
| 60 trading days | C$11.32 | C$9.20 – C$13.93 |
| 90 trading days | C$11.95 | C$9.26 – C$15.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Profound Medical's upcoming financial results and strategic initiatives, as these could significantly influence stock performance in the near term.
Profound Medical Corp's stock drops 1.82%
The current market cap stands at CA$339.39 million, signaling a need for strong performance to attract investor interest.
Bull case
If Profound Medical can effectively utilize its recent financial results and strategic initiatives, it might regain investor confidence and turn around the current downward trend.
Bear case
Ongoing skepticism from investors and a lack of positive news could lead to further drops in Profound Medical's stock price, especially if the upcoming financial results fall short of expectations.
Market Reaction to Recent Developments
The recent decline in Profound Medical's stock price reflects a general market reaction to the company's upcoming financial results. Investors are cautious, particularly due to the absence of immediate positive news. The anticipation surrounding the release of Q4 and full-year results is strong, but uncertainty remains.
What’s Next for Profound Medical?
As Profound Medical prepares to disclose its financial performance for 2025, all eyes will be on the numbers. Investors hope the company will show growth and strategic progress, but the recent stock performance suggests that confidence is waning. The upcoming investor call on March 13 could be a crucial moment for the company's stock trajectory.
Advertisement
